PT87207A - Process for preparing recombinant htlv-iii proteins and uses thereof - Google Patents

Process for preparing recombinant htlv-iii proteins and uses thereof

Info

Publication number
PT87207A
PT87207A PT87207A PT8720788A PT87207A PT 87207 A PT87207 A PT 87207A PT 87207 A PT87207 A PT 87207A PT 8720788 A PT8720788 A PT 8720788A PT 87207 A PT87207 A PT 87207A
Authority
PT
Portugal
Prior art keywords
preparing recombinant
iii proteins
recombinant htlv
htlv
proteins
Prior art date
Application number
PT87207A
Other languages
English (en)
Inventor
Scott D Putney
Debra Lynn
Kashayar Javaherian
William T Muller
John Farley
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Publication of PT87207A publication Critical patent/PT87207A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT87207A 1987-10-09 1988-04-08 Process for preparing recombinant htlv-iii proteins and uses thereof PT87207A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10770387A 1987-10-09 1987-10-09

Publications (1)

Publication Number Publication Date
PT87207A true PT87207A (pt) 1989-07-31

Family

ID=22318013

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87207A PT87207A (pt) 1987-10-09 1988-04-08 Process for preparing recombinant htlv-iii proteins and uses thereof

Country Status (10)

Country Link
EP (1) EP0311228A3 (pt)
JP (1) JPH01193299A (pt)
KR (1) KR890006672A (pt)
AU (1) AU614535B2 (pt)
DK (1) DK196088A (pt)
FI (1) FI882741A (pt)
IL (1) IL86153A0 (pt)
NO (1) NO881502L (pt)
NZ (1) NZ224393A (pt)
PT (1) PT87207A (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
US5914109A (en) * 1990-06-15 1999-06-22 New York University Heterohybridomas producing human monoclonal antibodies to HIV-1
IL98845A0 (en) * 1990-07-19 1992-07-15 Merck & Co Inc Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
HUT70461A (en) * 1992-04-01 1995-10-30 Merck Anc Co Inc Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv invention
PT728015E (pt) 1992-06-18 2006-07-31 Creagen Inc Antigenes polipeptidicos combinatoriais
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO794196L (no) * 1978-12-22 1980-06-24 Biogen Nv Fremgangsmaate ved fremstilling av et rekombinert dna molekyl
JPS5761110A (en) * 1980-09-30 1982-04-13 Kitagawa Tekkosho:Kk Formation of columnar solidified portion in soft ground
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus

Also Published As

Publication number Publication date
FI882741A0 (fi) 1988-06-09
AU2117388A (en) 1989-04-27
NZ224393A (en) 1990-08-28
AU614535B2 (en) 1991-09-05
DK196088D0 (da) 1988-04-11
EP0311228A2 (en) 1989-04-12
EP0311228A3 (en) 1990-05-02
FI882741A (fi) 1989-04-10
KR890006672A (ko) 1989-06-15
NO881502D0 (no) 1988-04-07
NO881502L (no) 1989-04-10
JPH01193299A (ja) 1989-08-03
IL86153A0 (en) 1988-11-15
DK196088A (da) 1989-04-10

Similar Documents

Publication Publication Date Title
FI874787A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK518988A (da) Vanduoploeseligt polypeptidpraeparat
PT86600A (pt) Process for the preparation of anticoagulant peptides
EP0243929A3 (en) Polypeptide and protein derivatives and process for their preparation
ATA257190A (de) Virales polypeptid
DK97790A (da) Renin-inhiberende peptider
DK603888D0 (da) Rekombinant virus
PT88425A (pt) Dna sequences recombinant dna molecules and processes for producing soluble t4 proteins
DK299087D0 (da) Proteins and derivatives thereof
DK565987A (da) Substituerede aminosyrer
DK275788A (da) Fibrinolytiske proteiner
DK353788A (da) Polypeptidderivater
PT85461A (en) Process for preparing recombinant htlv-iii proteins and uses thereof
DK354389D0 (da) Polypeptid
PT87207A (pt) Process for preparing recombinant htlv-iii proteins and uses thereof
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK395288D0 (da) Proteiner
DK354989A (da) Modificerede proteiner
GB8713559D0 (en) Structural proteins
ZA883261B (en) Recombinant htlv-iii proteins and uses thereof
IE881482L (en) Recombinant htlv-iii proteins
ZA887596B (en) Process for preparing proteins
DK596888A (da) Rekombinant lymfotoksin

Legal Events

Date Code Title Description
FC3A Refusal

Effective date: 19941024